Clinical Trial Update: Hepatic Arterial Infusion of Raltetrexed With Oxaliplatin(SALOX) Versus FOLFOX in Advanced Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing hepatic arterial infusion raltetrexed with oxaliplatin (SALOX) vs FOLFOX in advanced hepatocellular carcinoma is ongoing with unknown st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• FOLFOX
• Raltetrexed with Oxaliplatin (SALOX) (raltetrexed with oxaliplatin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: UNKNOWN